The Poison That Built Safety

Before 1937, the United States Food and Drug Administration had no legal power to demand that a pharmaceutical company test a new medication for toxicity before selling it to the public. The law at the time cared intensely about whether a label lied, but remarkably little about whether the contents inside the bottle would kill you.

That posture changed when a Tennessee firm called the S.E. Massengill Company decided to manufacture Elixir Sulfanilamide. Sulfanilamide was a genuine wonder drug of the era, but finding a way to make it drinkable proved tricky. The company chose diethylene glycol as a solvent—a chemical cousin of antifreeze that is profoundly toxic to the human liver and kidneys.

The resulting elixir killed 107 people, a heartbreaking number of them children suffering from streptococcal infections who swallowed the sweet, deadly liquid and rapidly succumbed to acute renal failure.

When federal authorities moved in, they discovered a grim regulatory absurdity. Because diethylene glycol was not formally classified as a drug and the formula was not technically adulterated under the toothless 1906 Pure Food and Drugs Act, the FDA could not penalize the manufacturer for poisoning people. Instead, investigators had to rely on a pedantic linguistic technicality: historically, an elixir required an alcohol base. Because the company used glycol instead of alcohol, the product was technically mislabeled.

Public outrage over the tragedy swept away legal loopholes. The disaster galvanized Congress to pass the Federal Food, Drug, and Cosmetic Act of 1938, a landmark piece of legislation that fundamentally inverted American jurisprudence. For the first time, manufacturers were legally required to prove their medications were safe before putting them on shelves, creating the foundational blueprint for modern pharmaceutical regulation worldwide.